Epidemiology and Prevention of Transfusion‐Associated Human Immunodeficiency Virus Transmission in Sub‐Saharan Africa
Identifieur interne : 001282 ( Main/Exploration ); précédent : 001281; suivant : 001283Epidemiology and Prevention of Transfusion‐Associated Human Immunodeficiency Virus Transmission in Sub‐Saharan Africa
Auteurs : William Mcfarland [États-Unis] ; David Mvere [Zimbabwe] ; Wayne Shandera ; Arthur Reingold [États-Unis]Source :
- Vox Sanguinis [ 0042-9007 ] ; 1997-02.
Descripteurs français
- Wicri :
- geographic : Zaïre, Zimbabwe.
- topic : Transfusion sanguine, Don, Conférence internationale, Santé publique.
English descriptors
- KwdEn :
- Aids prevention, Aids prevention strategies, Antibody screening, Antibody testing, Autologous transfusions, Blood cells, Blood donation, Blood donations, Blood donor populations, Blood donors, Blood products, Blood screening, Blood supplies, Blood supply, Blood transfusion, Blood transfusion practices, Blood transfusion services, Blood transfusions, Cellular components, Defic syndr, Disease control, Donation, Donor, Donor exclusion criteria, Donor populations, East africa, Family health, Future technologies, High prevalence, High rates, High risk, Human error, Human immunodeficiency virus, Human immunodeficiency virus infection, Human immunodeficiency virus transmission, Immunodeficiency, Important source, Industrialised nations, Inexpensive strategies, Infection, International conference, Kenyan hospital, Kinshasa, Many areas, Nucleic acids, Piot, Public health, Raven press, Recent studies, Residual risk, Risk factor, Risk factor exclusion, Risk factor exclusion strategies, Risk factors, Rural senegal, Screening, Surveillance report, Transfusion, Transfusion complications, Transmission categories, West african city, Window period, Window period donation, Window period donations, Women children, Zaire, Zimbabwe.
- Teeft :
- Aids prevention, Aids prevention strategies, Antibody screening, Antibody testing, Autologous transfusions, Blood cells, Blood donation, Blood donations, Blood donor populations, Blood donors, Blood products, Blood screening, Blood supplies, Blood supply, Blood transfusion, Blood transfusion practices, Blood transfusion services, Blood transfusions, Cellular components, Defic syndr, Disease control, Donation, Donor, Donor exclusion criteria, Donor populations, East africa, Family health, Future technologies, High prevalence, High rates, High risk, Human error, Human immunodeficiency virus, Human immunodeficiency virus infection, Human immunodeficiency virus transmission, Immunodeficiency, Important source, Industrialised nations, Inexpensive strategies, Infection, International conference, Kenyan hospital, Kinshasa, Many areas, Nucleic acids, Piot, Public health, Raven press, Recent studies, Residual risk, Risk factor, Risk factor exclusion, Risk factor exclusion strategies, Risk factors, Rural senegal, Screening, Surveillance report, Transfusion, Transfusion complications, Transmission categories, West african city, Window period, Window period donation, Window period donations, Women children, Zaire, Zimbabwe.
Abstract
Background and objectives: Compared to industrialised nations, countries in sub‐Saharan Africa experience a greater amount of transfusion‐associated HIV transmission due to high rates of transfusion in some groups of patients, a higher incidence and prevalence of HIV infection in donor populations, a lack of HIV antibody screening in some areas, and a higher residual risk of contamination in blood supplies despite antibody screening. Materials and methods: Epidemiologic review. Results: Epidemiologic evidence supports the effectiveness of three relatively inexpensive strategies to prevent transfusion‐associated HIV transmission in sub‐Saharan Africa: HIV antibody screening, avoidance of unnecessary use of blood products, and exclusion of donors at high risk of infection. Such prevention strategies have not been universally implemented. Conclusions: International aid to establish and maintain HIV antibody screening programmes, implementation of sound criteria for transfusion, and the search for HIV risk factors to use as donor exclusion criteria must be expanded in the region.
Url:
DOI: 10.1046/j.1423-0410.1997.7220085.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000467
- to stream Istex, to step Curation: 000467
- to stream Istex, to step Checkpoint: 000766
- to stream Main, to step Merge: 001386
- to stream Main, to step Curation: 001282
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Epidemiology and Prevention of Transfusion‐Associated Human Immunodeficiency Virus Transmission in Sub‐Saharan Africa</title><author><name sortKey="Mcfarland, William" sort="Mcfarland, William" uniqKey="Mcfarland W" first="William" last="Mcfarland">William Mcfarland</name></author><author><name sortKey="Mvere, David" sort="Mvere, David" uniqKey="Mvere D" first="David" last="Mvere">David Mvere</name></author><author><name sortKey="Shandera, Wayne" sort="Shandera, Wayne" uniqKey="Shandera W" first="Wayne" last="Shandera">Wayne Shandera</name></author><author><name sortKey="Reingold, Arthur" sort="Reingold, Arthur" uniqKey="Reingold A" first="Arthur" last="Reingold">Arthur Reingold</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:78A7054CC7B6E44090DCE05F08579A05E9950A10</idno><date when="1997" year="1997">1997</date><idno type="doi">10.1046/j.1423-0410.1997.7220085.x</idno><idno type="url">https://api.istex.fr/document/78A7054CC7B6E44090DCE05F08579A05E9950A10/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000467</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000467</idno><idno type="wicri:Area/Istex/Curation">000467</idno><idno type="wicri:Area/Istex/Checkpoint">000766</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000766</idno><idno type="wicri:doubleKey">0042-9007:1997:Mcfarland W:epidemiology:and:prevention</idno><idno type="wicri:Area/Main/Merge">001386</idno><idno type="wicri:Area/Main/Curation">001282</idno><idno type="wicri:Area/Main/Exploration">001282</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Epidemiology and Prevention of Transfusion‐Associated Human Immunodeficiency Virus Transmission in Sub‐Saharan Africa</title><author><name sortKey="Mcfarland, William" sort="Mcfarland, William" uniqKey="Mcfarland W" first="William" last="Mcfarland">William Mcfarland</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for AIDS Prevention Studies, University of California, San Francisco, Calif.</wicri:regionArea><wicri:noRegion>Calif.</wicri:noRegion></affiliation></author><author><name sortKey="Mvere, David" sort="Mvere, David" uniqKey="Mvere D" first="David" last="Mvere">David Mvere</name><affiliation wicri:level="1"><country xml:lang="fr">Zimbabwe</country><wicri:regionArea>Zimbabwe National Blood Transfusion Service, Harare</wicri:regionArea><wicri:noRegion>Harare</wicri:noRegion></affiliation></author><author><name sortKey="Shandera, Wayne" sort="Shandera, Wayne" uniqKey="Shandera W" first="Wayne" last="Shandera">Wayne Shandera</name><affiliation><wicri:noCountry code="subField">Tex.</wicri:noCountry></affiliation></author><author><name sortKey="Reingold, Arthur" sort="Reingold, Arthur" uniqKey="Reingold A" first="Arthur" last="Reingold">Arthur Reingold</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Epidemiology, School of Public Health, University of California, Berkeley, Calif.</wicri:regionArea><wicri:noRegion>Calif.</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Vox Sanguinis</title><title level="j" type="alt">VOX SANGUINIS</title><idno type="ISSN">0042-9007</idno><idno type="eISSN">1423-0410</idno><imprint><biblScope unit="vol">72</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="85">85</biblScope><biblScope unit="page" to="92">92</biblScope><biblScope unit="page-count">8</biblScope><publisher>Blackwell Science Ltd</publisher><pubPlace>Oxford UK</pubPlace><date type="published" when="1997-02">1997-02</date></imprint><idno type="ISSN">0042-9007</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0042-9007</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aids prevention</term><term>Aids prevention strategies</term><term>Antibody screening</term><term>Antibody testing</term><term>Autologous transfusions</term><term>Blood cells</term><term>Blood donation</term><term>Blood donations</term><term>Blood donor populations</term><term>Blood donors</term><term>Blood products</term><term>Blood screening</term><term>Blood supplies</term><term>Blood supply</term><term>Blood transfusion</term><term>Blood transfusion practices</term><term>Blood transfusion services</term><term>Blood transfusions</term><term>Cellular components</term><term>Defic syndr</term><term>Disease control</term><term>Donation</term><term>Donor</term><term>Donor exclusion criteria</term><term>Donor populations</term><term>East africa</term><term>Family health</term><term>Future technologies</term><term>High prevalence</term><term>High rates</term><term>High risk</term><term>Human error</term><term>Human immunodeficiency virus</term><term>Human immunodeficiency virus infection</term><term>Human immunodeficiency virus transmission</term><term>Immunodeficiency</term><term>Important source</term><term>Industrialised nations</term><term>Inexpensive strategies</term><term>Infection</term><term>International conference</term><term>Kenyan hospital</term><term>Kinshasa</term><term>Many areas</term><term>Nucleic acids</term><term>Piot</term><term>Public health</term><term>Raven press</term><term>Recent studies</term><term>Residual risk</term><term>Risk factor</term><term>Risk factor exclusion</term><term>Risk factor exclusion strategies</term><term>Risk factors</term><term>Rural senegal</term><term>Screening</term><term>Surveillance report</term><term>Transfusion</term><term>Transfusion complications</term><term>Transmission categories</term><term>West african city</term><term>Window period</term><term>Window period donation</term><term>Window period donations</term><term>Women children</term><term>Zaire</term><term>Zimbabwe</term></keywords><keywords scheme="Teeft" xml:lang="en"><term>Aids prevention</term><term>Aids prevention strategies</term><term>Antibody screening</term><term>Antibody testing</term><term>Autologous transfusions</term><term>Blood cells</term><term>Blood donation</term><term>Blood donations</term><term>Blood donor populations</term><term>Blood donors</term><term>Blood products</term><term>Blood screening</term><term>Blood supplies</term><term>Blood supply</term><term>Blood transfusion</term><term>Blood transfusion practices</term><term>Blood transfusion services</term><term>Blood transfusions</term><term>Cellular components</term><term>Defic syndr</term><term>Disease control</term><term>Donation</term><term>Donor</term><term>Donor exclusion criteria</term><term>Donor populations</term><term>East africa</term><term>Family health</term><term>Future technologies</term><term>High prevalence</term><term>High rates</term><term>High risk</term><term>Human error</term><term>Human immunodeficiency virus</term><term>Human immunodeficiency virus infection</term><term>Human immunodeficiency virus transmission</term><term>Immunodeficiency</term><term>Important source</term><term>Industrialised nations</term><term>Inexpensive strategies</term><term>Infection</term><term>International conference</term><term>Kenyan hospital</term><term>Kinshasa</term><term>Many areas</term><term>Nucleic acids</term><term>Piot</term><term>Public health</term><term>Raven press</term><term>Recent studies</term><term>Residual risk</term><term>Risk factor</term><term>Risk factor exclusion</term><term>Risk factor exclusion strategies</term><term>Risk factors</term><term>Rural senegal</term><term>Screening</term><term>Surveillance report</term><term>Transfusion</term><term>Transfusion complications</term><term>Transmission categories</term><term>West african city</term><term>Window period</term><term>Window period donation</term><term>Window period donations</term><term>Women children</term><term>Zaire</term><term>Zimbabwe</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Zaïre</term><term>Zimbabwe</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Transfusion sanguine</term><term>Don</term><term>Conférence internationale</term><term>Santé publique</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract">Background and objectives: Compared to industrialised nations, countries in sub‐Saharan Africa experience a greater amount of transfusion‐associated HIV transmission due to high rates of transfusion in some groups of patients, a higher incidence and prevalence of HIV infection in donor populations, a lack of HIV antibody screening in some areas, and a higher residual risk of contamination in blood supplies despite antibody screening. Materials and methods: Epidemiologic review. Results: Epidemiologic evidence supports the effectiveness of three relatively inexpensive strategies to prevent transfusion‐associated HIV transmission in sub‐Saharan Africa: HIV antibody screening, avoidance of unnecessary use of blood products, and exclusion of donors at high risk of infection. Such prevention strategies have not been universally implemented. Conclusions: International aid to establish and maintain HIV antibody screening programmes, implementation of sound criteria for transfusion, and the search for HIV risk factors to use as donor exclusion criteria must be expanded in the region.</div></front></TEI><affiliations><list><country><li>Zimbabwe</li><li>États-Unis</li></country></list><tree><noCountry><name sortKey="Shandera, Wayne" sort="Shandera, Wayne" uniqKey="Shandera W" first="Wayne" last="Shandera">Wayne Shandera</name></noCountry><country name="États-Unis"><noRegion><name sortKey="Mcfarland, William" sort="Mcfarland, William" uniqKey="Mcfarland W" first="William" last="Mcfarland">William Mcfarland</name></noRegion><name sortKey="Reingold, Arthur" sort="Reingold, Arthur" uniqKey="Reingold A" first="Arthur" last="Reingold">Arthur Reingold</name></country><country name="Zimbabwe"><noRegion><name sortKey="Mvere, David" sort="Mvere, David" uniqKey="Mvere D" first="David" last="Mvere">David Mvere</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001282 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001282 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:78A7054CC7B6E44090DCE05F08579A05E9950A10
|texte= Epidemiology and Prevention of Transfusion‐Associated Human Immunodeficiency Virus Transmission in Sub‐Saharan Africa
}}
| This area was generated with Dilib version V0.6.31. |  |